Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters.

@article{Usoh2010ProspectiveRS,
  title={Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters.},
  author={Fred Usoh and Anil P. Hingorani and Enrico Ascher and Alexander Shiferson and Nirav Patel and K Saraswathy Gopal and Natalia Marks and Theresa Jacob},
  journal={Journal of vascular surgery},
  year={2010},
  volume={52 2},
  pages={394-9}
}
OBJECTIVE Although anticoagulation remains the mainstay of treatment for deep venous thrombosis, the use of inferior vena cava (IVC) filters when anticoagulation has failed or when contraindicated remains a safe and effective treatment. Greenfield (Boston Scientific, Natick, Mass) and TrapEase (Cordis, Bridgewater, NJ) filters are arguably among the most… CONTINUE READING